CLFA - Overview: Cryptococcus Antigen Screen with Titer, Spinal Fluid
Aiding in the diagnosis of cryptococcosis This test should not be performed as a screening procedure for the general population. This test should not be used as a test of cure or to guide treatment decisions.
RHUT - Overview: Rheumatoid Factor, Serum
Diagnosis and prognosis of rheumatoid arthritis
Aiding in the diagnosis of Helicobacter pylori infection and prediction of clarithromycin resistance or susceptibility directly from stool
HSVC - Overview: Herpes Simplex Virus (HSV), Molecular Detection, PCR, Spinal Fluid
Aiding in the rapid diagnosis of herpes simplex virus (HSV)-1 and HSV-2 infections of the central nervous system
DIPGS - Overview: Diphtheria Toxoid IgG Antibody, Serum
Determining a patient's immunological response to diphtheria toxoid vaccination Aiding in the evaluation of immunodeficiency
LEPDT - Overview: Leptospira, IgM, Serum
Aiding in the diagnosis of leptospirosis This test is not useful for establishing cure or response to therapy.
TTIGS - Overview: Tetanus Toxoid IgG Antibody, Serum
Assessing antibody response to the tetanus toxoid vaccine, which should be performed at least 3 weeks after immunization Aiding in the evaluation of immunodeficiency This test should not be used to diagnose tetanus infection.
CMVG - Overview: Cytomegalovirus (CMV) Antibodies, IgG, Serum
Determining whether a patient (especially transplant recipients and organ and blood donors) has had a recent infection or previous exposure to cytomegalovirus
MPPG - Overview: Mumps Virus Antibody, IgG, Serum
Determination of postimmunization immune response of individuals to the mumps vaccine Documentation of previous infection with mumps virus in an individual with no previous record of immunization to mumps virus
BILHA - Overview: Schistosoma species Antibody, IgG, Serum
Detection of antibodies to Schistosoma species
Mayo Clinic Laboratory and pathology research roundup: November 9 - Insights
This week’s research roundup features: The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Mayo Clinic Laboratory and pathology research roundup: January 11 - Insights
This week’s research roundup features: The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Mayo Clinic Laboratory and pathology research roundup: April 12 - Insights
This Feature Includes: Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure.
Roshini Abraham, Ph.D., Elected President of Clinical Immunology Society - Insights
Roshini Abraham, Ph.D., Consultant in the Division of Clinical Biochemistry and Immunology at Mayo Clinic in Rochester, Minnesota, has been elected to serve a two-year term as President of the Clinical Immunology Society.
Mayo Clinic Laboratory and pathology research roundup: January 25 - Insights
Today's Topic Features: Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.